Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2025

Investments, All Other Investments [Abstract]

Schedule of Cash and Cash Equivalents, Restricted Cash and Investments

The following table summarizes the Company’s cash and cash equivalents, amortized cost, gross unrealized gains, gross unrealized losses, and fair value by significant category reported as cash and cash equivalents and restricted cash as of March 31, 2025 and December 31, 2024:

	March 31, 2025
	Reported as:
(in thousands)	Cash and Cash Equivalents		Restricted Cash- current
Cash	$	1,463	$	-
Level 2
Money market funds		9,138		88
Subtotal		9,138		88
Total assets measured at fair value	$	10,601	$	88

	December 31, 2024
	Reported as:
(in thousands)	Cash and Cash Equivalents		Restricted Cash- current
Cash	$	969	$	-
Level 2
Money market funds		11,248		219
Subtotal		11,248		219
Total assets measured at fair value	$	12,217	$	219